Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 6,000 VTVT shares, $210.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | vTv Therapeutics Inc. (VTVT) | Grant/Award | 6,000 | $210.5K |
| Jun 10, 2026 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| May 26, 2026 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/Award | 1,700 | n/a |
| Dec 16, 2025 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/Award | 458 | n/a |
| Sep 24, 2025 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| Jul 24, 2025 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/Award | 30,000 | n/a |
| Jun 12, 2025 | vTv Therapeutics Inc. (VTVT) | Grant/Award | 4,000 | $66.4K |
| Jun 2, 2025 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 16,634 | n/a |
| Jun 27, 2024 | vTv Therapeutics Inc. (VTVT) | Grant/Award | 6,000 | $103.3K |
| Jun 4, 2024 | MYRIAD GENETICS INC (MYGN) | Sale | 3,788 | $83.5K |